Malignant rectal GIST managed with chemotherapy (Imatinib Mesylate): A case report and a comprehensive review

Radiol Case Rep. 2024 Jan 16;19(4):1424-1431. doi: 10.1016/j.radcr.2023.12.046. eCollection 2024 Apr.

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract, arising from the interstitial cells of Cajal. GIST comprises about 1% of all GI tumors. Rectal GISTs are rare and comprise of approximately 5% of all GISTs and only 0.1% of rectal tumors are found to be GISTs. Rectal GISTs may be diagnosed incidentally or present with symptoms, including defecation problems, bleeding, and/or pain. We report a case of a 46-year-old male with rectal GIST metastasized to the liver and bilateral lung parenchyma managed by Imatinib Mesylate (IM) regimen. Rectal GIST although being rare, must be considered as a differential diagnosis in a patient presenting with defecatory problems with bleeding.

Keywords: Case report; Gastrointestinal stromal tumors; Imatinib Mesylate; Metastasis; Rare; Rectal tumors.

Publication types

  • Case Reports